Výsledky vyhledávání

Histopathology of bone marrow reconstitution after umbilical cord blood transplantation for hematological diseases

Autor: Norimichi Hattori, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Hidetoshi Nakashima, Toshiko Yamochi-Onizuka, Isao Matsuda, Eisuke Shiozawa, Takashi Maeda, Hidekazu Ota, Bungo Saito, Takako Usui, Daisuke Adachi, Masafumi Takimoto, Homma Mayumi, Kouji Yanagisawa

Publikováno v: Pathology International. 58:126-132

To study hematopoietic reconstitution in umbilical cord blood transplantation (CBT), bone marrow (BM) histology was investigated in 35 biopsies after bone marrow transplantation (BMT) and in 40 biopsies after CBT. BM biopsies were obtained at differe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0cb8804b2fede35e19e09bbf2661b9f4
https://doi.org/10.1111/j.1440-1827.2007.02200.x

Zobrazit plný text záznamu

Histopathological bone marrow changes after reduced-intensity hematopoietic stem cell transplantation for follicular lymphoma involving bone marrow

Autor: Shigeru Tomoyasu, Eisuke Shiozawa, Tsuyoshi Nakamaki, Toshiko Yamochi-Onizuka, Norimichi Hattori, Hidetoshi Nakashima, Daisuke Adachi, Masafumi Takimoto, Takashi Maeda, Kouji Yanagisawa, Hidekazu Ota, Bungo Saito, Keiichiro Kawakami, Takako Usui

Publikováno v: Pathology International. 57:378-382

Allogeneic stem cell transplantation (allo-SCT) is used as curative therapy for malignant lymphoma, and reduced-intensity hematopoietic stem cell transplantation (RIST) is sometimes performed to avoid the toxicity and mortality associated with myeloa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c0978c706a0231bc7e95561454366f
https://doi.org/10.1111/j.1440-1827.2007.02110.x

Zobrazit plný text záznamu

[Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjögren syndrome]

Autor: Norimichi, Hattori, Hidetoshi, Nakashima, Takako, Usui, Takashi, Maeda, Kouji, Yanagisawa, Tsuyoshi, Nakamaki, Shigeru, Tomoyasu

Publikováno v: [Rinsho ketsueki] The Japanese journal of clinical hematology. 48(12)

A 66-year-old woman presented with anemia in January 2006. She was admitted to our Department in February, after laboratory data showed pancytopenia and bone marrow biopsy reticulin fibrosis. The results of the diagnostic work-up, which included the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b5bc12083ef69eea26ee3e49eb750bf9
https://pubmed.ncbi.nlm.nih.gov/18203513

Zobrazit plný text záznamu

Histopathology of bone marrow reconstitution after umbilical cord blood transplantation for hematological diseases

Autor: Takashi, Maeda, Eisuke, Shiozawa, Homma, Mayumi, Takako, Usui, Hidetoshi, Nakashima, Norimichi, Hattori, Daisuke, Adachi, Bungo, Saito, Kouji, Yanagisawa, Isao, Matsuda, Tsuyoshi, Nakamaki, Shigeru, Tomoyasu, Toshiko, Yamochi-Onizuka, Masafumi, Takimoto, Hidekazu, Ota

Publikováno v: Pathology international. 58(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6d4e6d8c86c48b4c7caa9dfb954d424a
https://pubmed.ncbi.nlm.nih.gov/18199163

Zobrazit plný text záznamu

Increased Expression of Cyclin A1 mRNA Is a Novel Adverse Prognostic Indicator for Acute Promyelocytic Leukemia in Differentiation Therapy by All-Trans Retinoic Acid

Autor: Shigeru Tomoyasu, Mayumi Honma, Hidetoshi Nakashima, Bungo Saito, Takako Usui, Daisuke Adachi, Tsuyoshi Nakamaki, Masamichi Hattori

Publikováno v: Blood. 108:2344-2344

The retinoic acid syndrome (RAS) is a most important complication in all-trans retinoic acid (ATRA)-based remission induction therapy in acute promelocytic leukemia (APL). Predictive factors associated with the development of RAS have not been fully

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f7ec5eeb6ea1a95bf78a732ee4f3a560
https://doi.org/10.1182/blood.v108.11.2344.2344

Zobrazit plný text záznamu

Treatment Effect of Rituximab Plus Chemotherapy Is Obtained by Improving Survival from Non-Germinal Center-Type Untreated Diffuse Large B-Cell Lymphoma

Autor: Toshiko Yamochi-Onizuka, Takako Usui, Hidekazu Ota, Norimichi Hattori, Takashi Maeda, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Daisuke Adachi, Bungo Saito, Hidetoshi Nakashima, Masafumi Takimoto, Eisuke Shiozawa

Publikováno v: Blood. 108:2032-2032

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disorder that can be classified into at least three subgroups according to DNA microarray-based expression profiles: germinal center B-cell-like (GC) type, activated B-cell-like type, and type

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::15ee16729e9b8fa2ca76520d69a7646d
https://doi.org/10.1182/blood.v108.11.2032.2032

Zobrazit plný text záznamu

Altered Expressions of CD30, c-Jun N-Terminal Kinase, NF-κB and JunB Are Involved in Disease Progression in CD30-Positive Anaplastic Large Cell Lymphoma

Autor: Takashi Maeda, Hidetoshi Nakashima, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Masamichi Hattori, Takako Usui, Kunihiko Fukuchi

Publikováno v: Blood. 106:2827-2827

Anaplastic large cell lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is an aggressive T cell lymphoma. CD30 is a characteristic cell surface protein overexpressed in ALCL cells as well as in malignant cells of Hodgkin lymphoma.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::22a331658b543220775237a05747700e
https://doi.org/10.1182/blood.v106.11.2827.2827

Zobrazit plný text záznamu

Analysis of Factors Involved in Malignant Progression of Anaplastic Large Cell Lymphoma Kinase (ALK) -Negative Anaplastic Large Cell Lymphoma

Autor: Shigeru Tomoyasu, Takashi Maeda, Hidetoshi Nakashima, Takako Usui, Masamichi Hattori, Yoshio Honma, Tsuyoshi Nakamaki

Publikováno v: Blood. 104:3272-3272

Anaplastic large cell lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is a aggressive T cell lymphoma. The 5-year survival rate of ALK-negative ALCL is less than those of ALK-positive ALCL. To address factor(s)involved in maligna

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e5b83aa54bff9ee9d5e8e99b85a217d1
https://doi.org/10.1182/blood.v104.11.3272.3272

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání